SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
16 references·2 citing·33 second hop
Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases (2010)Economic Evaluation of Lifestyle Interven…What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)What Does the Value of Modern…The NICE Cost-Effectiveness Threshold (2008)The NICE Cost-Effectiveness T…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in…Methods for the economic evaluation of health care programmes, 3rd ed (2006)Methods for the economic eval…Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Good Practice Guidelines for …Bias in published cost effectiveness studies: systematic review (2006)Bias in published cost effect…The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)The Cost-Effectiveness of Lif…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria (2005)Criteria list for assessment …Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Generalisability in economic …Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…Development of WHO guidelines on generalized cost-effectiveness analysis (2000)Development of WHO guidelines…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies (2016)Lifestyle Interventions to Pr…The Economic Costs of Diabetes: Is It Time for a New Treatment Paradigm? (2013)The Economic Costs of Diabete…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)Inductive Teaching and Learning Methods: Definitions, Comparisons, and Research Bases (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments (2006)Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications (2008)AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users (2015)How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study (2003)Productivity Costs of Cancer Mortality in the United States: 2000–2020 (2008)Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)The cost-effectiveness of digital health interventions: A systematic review of the literature (2022)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)Economic Costs of Diabetes in the U.S. in 2012 (2013)The State of US Health, 1990-2010 (2013)Social Determinants of Health and Diabetes: A Scientific Review (2020)Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs (2012)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Economic Costs of Diabetes in the U.S. in 2022 (2023)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,821 cited
  • 2008Economic Costs of Diabetes in the U.S. in 20071,323 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 2006Methods for the economic evaluation of health care programmes, 3rd ed956 cited
  • 2008The NICE Cost-Effectiveness Threshold868 cited
  • 2005Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria858 cited
  • 2008Economic Costs of Diabetes in the U.S. in 2007781 cited
  • 2005The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance703 cited
  • 2000Development of WHO guidelines on generalized cost-effectiveness analysis578 cited
  • 2008What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?578 cited
  • 2006Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

504 cited
  • 2004Generalisability in economic evaluation studies in healthcare: a review and case studies441 cited
  • 2006Bias in published cost effectiveness studies: systematic review383 cited
  • Cited by

    • 2016Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies94 cited
    • 2013The Economic Costs of Diabetes: Is It Time for a New Treatment Paradigm?90 cited